Cyclic orynotides for systemic MDR candidiasis
Ended Project Grant Awarded Last action
- Award ID
- R44AI142959
- Recipient
-
Oryn Therapeutics, Inc. UEI STTZK8ZF37W4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,224,959
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Funding
-
- $5,233,408.00 Federal
- $991,551.00 Non-federal
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $983,348 | $0 | |
| Amendment | $983,348 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $991,551 | $0 | |
| Amendment | $991,551 | $991,551 | |
| Amendment | $998,632 | $0 | |
| Original award | $284,978 | $0 |
Quick answers
Who received award R44AI142959?
R44AI142959 was awarded to Oryn Therapeutics, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 7, 2019.
How much is award R44AI142959 worth?
$6,224,959 has been obligated on R44AI142959: $5,233,408 in federal funding and $991,551 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award